Similarly, downregulation of TGFBR3 expression in hepatocellular carcinoma (HCC) was driven by HCC cell-derived EVs carrying miR-378b, which increased progression and angiogenesis (Chen W. et al., 2021). This evidence concerns the gene TGFBR3 and hepatocellular carcinoma.